TScan Therapeutics Inc. (NASDAQ:TCRX), a clinical-stage biopharmaceutical company with a market capitalization of $139.57 million, is poised at a critical juncture in its development of innovative ...

We recently compiled a list of the 10 Best Russell 2000 Stocks to Invest in According to Analysts. In this article, we are ...

L'Oreal's Cell BioPrint, unveiled at CES 2025, is designed to take the mystery and frustration out of choosing skin care ...

Today, Plug's stock trades about 99% below its IPO price. It also slumped about 10% over the past 12 months as investors ...

With that in mind, let's consider two stocks that haven't performed well recently and are now near their 52-week lows but ...

The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...

NerdWallet's credit cards team selects the best credit cards in each category ... you'll file a claim with the company that administers the cell phone benefit, and you'll be reimbursed.

If we assume all patients who began treatment with Casgevy last year progress to the administration stage, CRISPR and Vertex ...

The Rancho Viejo project, a 96-megawatt (MW) solar facility and 48 MW battery energy storage system has been embroiled in ...

Nintendo is still sticking with the tradition of the company and loves to bring back older games in one form or another while ...

Volvo is trying to hit ambitious targets for fuel efficiency and EVs by 2040. And it's inventing its path to get there.

We've rounded up our top picks from this year's tech showcase ranging from skin-care devices and luxe earbuds, to stylish 4K ...